A mixed-ligand metal–metal bonded diruthenium complex having the formula Ru2(2,4,6-(CH3)3ap)3(O2CCH3)Cl where ap is the anilinopyridinate anion was synthesized from the reaction of Ru2(O2CCH3)4Cl and H(2,4,6-(CH3)3ap), after which the isolated product was structurally, spectroscopically and electrochemically characterized. The crystal structure reveals an unusual arrangement of the bridging ligands around the dimetal unit where one ruthenium atom is coordinated to one anilino and two pyridyl nitrogen atoms while the other ruthenium atom is coordinated to one pyridyl and two anilino nitrogen atoms. To our knowledge, Ru2(2,4,6-(CH3)3ap)3(O2CCH3)Cl is the only example of a mixed-ligand diruthenium complex of the type [Ru2L3(O2CCH3)]+, where L is an unsymmetrical anionic bridging ligand that has been structurally characterized with a “(2,1)” geometric conformation of the bridging ligands, all others being “(3,0)”. The initial Ru25+ compound in CH2Cl2 or CH3CN containing 0.1 M tetra-n-butylammonium perchlorate (TBAP) undergoes up to four one-electron redox processes involving the dimetal unit. The Ru25+/4+ and Ru25+/6+ processes were characterized under N2 using thin-layer UV-visible spectroelectrochemistry and this data is compared to UV-visible spectral changes obtained during similar electrode reactions for related diruthenium compounds having the formula Ru2L4Cl or Ru2L3(O2CCH3)Cl where L is an anionic bridging ligand. Ru2(2,4,6-(CH3)3ap)3(O2CCH3)Cl was also examined by UV-visible and FTIR spectroelectrochemistry under a CO atmosphere and two singly reduced Ru24+ species, [Ru2(2,4,6-(CH3)3ap)3(O2CCH3)(CO)Cl]− and Ru2(2,4,6-(CH3)3ap)3(O2CCH3)(CO) were in situ generated for further characterization. The CO-bound complexes could be further reduced and exhibited additional reductions to their Ru23+ and Ru22+ oxidation states.
23 January 2022 in Journal of Organometallic Chemistry
Treatment of the known half-sandwich complexes of the type [(η6-C6H6)RuCl2(P(OR)3)] (R = Me or Ph) with SnCl2 yielded three new half-sandwich ruthenium complexes (C1–C3): [(η6-C6H6)RuCl(SnCl3)(P(OMe)3)] (C1), [(η6-C6H6)RuCl(SnCl3)(P(OPh)3)] (C2) and the bis-stannyl complex [(η6-C6H6)Ru(SnCl3)2(P(OMe)3)] (C3) by facile insertion of SnCl2 into the Ru–Cl bonds. Treatment of the known complexes [(η6-C6H6)RuCl(SnCl3)(PPh3)] and [(η6-C6H6)RuCl2(PPh3)] with 4-dimethylaminopyridine (DAMP) and ammonium tetrafluoroborate afforded the complex salts: [(η6-C6H6)Ru(SnCl3)(PPh3)(DAMP)]+BF4− (C4) and [(η6-C6H6)RuCl(PPh3)(DAMP)]+BF4− (C5) respectively. Complexes C1–C5 have been fully characterized by spectroscopic means (IR, UV–vis, multinuclear NMR, ESI–MS) and their thermal behaviour elucidated by thermal gravimetric analysis (TGA). Structural characterization by single crystal X-ray crystallography of the novel complex C2 and [(η6-C6H6)RuCl2(P(OPh)3)], the latter having escaped elucidation by this method, is also reported. Finally, the cytotoxicity of the complexes was determined on the A2780 (human ovarian cancer), A2780cisR (human ovarian cis-platin-resistant cancer), and the HEK293 (human embryonic kidney) cell lines and discussed, and an attempt is made to elucidate the effect of the stannyl ligand on cytotoxicity.